Jinshi data, January 5th news, Puli Pharmaceuticals announced that the company's stocks and convertible bonds will be suspended from trading on Monday, January 6, 2025, and will resume trading on Tuesday, January 7, 2025; the company's stock will be subject to 'delisting risk warning' starting from the opening of trading on January 7, 2025, and the stock abbreviation will be changed from 'Puli Pharmaceuticals' to '*ST Puli', with the stock code remaining as '300630'; after the implementation of the delisting risk warning, the daily trading limit for the company's stock remains at 20%.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin